作者：
C Y,Cheah [1]
;
K E,Herbert [2]
;
K,O'Rourke [3]
;
G A,Kennedy [4]
;
A,George [5]
;
P L,Fedele [6]
;
M,Gilbertson [7]
;
S Y,Tan [6]
;
D S,Ritchie [1]
;
S S,Opat [7]
;
H M,Prince [8]
;
M,Dickinson [1]
;
K,Burbury [1]
;
M,Wolf [2]
;
E H,Januszewicz [5]
;
C S,Tam [1]
;
D A,Westerman [1]
;
D A,Carney [1]
;
S J,Harrison [1]
;
J F,Seymour [1]
作者单位：
1] Department of Haematology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, Victoria 8006, Australia [2] Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
[1]
1] Department of Haematology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, Victoria 8006, Australia [2] Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia [3] Cabrini Medical Centre, Malvern, Victoria, Australia.
[2]
Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
[3]
1] Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia [2] University of Queensland, St Lucia, Queensland, Australia.
[4]
Department of Haematology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, Victoria 8006, Australia.
[5]
Department of Haematology, Monash Health, Clayton, Victoria, Australia.
[6]
1] Department of Haematology, Monash Health, Clayton, Victoria, Australia [2] Department of Haematology, Monash University, Clayton, Victoria, Australia.
[7]
1] Department of Haematology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, Victoria 8006, Australia [2] Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia [3] Cabrini Medical Centre, Malvern, Victoria, Australia [4] Department of Haematology, Monash University, Clayton, Victoria, Australia.
[8]
主题词
急性肾损伤(Acute Kidney Injury);青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);中枢神经系统肿瘤(Central Nervous System Neoplasms);环磷酰胺(Cyclophosphamide);阿糖胞苷(Cytarabine);地塞米松(Dexamethasone);无病生存(Disease-Free Survival);多柔比星(Doxorubicin);依托泊甙(Etoposide);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);异环磷酰胺(Ifosfamide);注射, 脊髓(Injections, Spinal);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);甲氨蝶呤(Methotrexate);中年人(Middle Aged);泼尼松(Prednisone);复发(Recurrence);回顾性研究(Retrospective Studies);危险性评估(Risk Assessment);存活率(Survival Rate);长春新碱(Vincristine);青年人(Young Adult)
DOI
10.1038/bjc.2014.405
PMID
25072255
发布时间
2022-03-16
换一批
换一批
